MPLT MapLight Therapeutics, Inc. - Common Stock
$25,52
Prezzo · Mag 20, 2026
Fondamentali al Mag 14, 2026
Intervallo 52 sett.
$12–$33
63% of range
Rating Analisti
BUY
13 analysts
Prezzo Obiettivo
$36
+41% upside
P/E (TTM)
-0.9
ROE
-151.1%
Margine di Profitto Netto
—
MPLT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$25.52
Capitalizzazione di Mercato
$773M
P/E (TTM)
-0.9
EPS (TTM)
$-18.56
Ricavi (TTM)
—
Rendimento div.
—
ROE
-151.1%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$12 – $33
MPLT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
—
EPS
$-18.56
2024-12-31
→
2025-12-31
Flusso di cassa libero
$-139M
2025-12-31
→
2025-12-31
Margini
—
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
MPLT
Mediana dei peer
P/E (TTM)
-0.9
—
P/B
1.7
5.6
Price / FCF (Prezzo / FCF)
-5.6
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
MPLT
Mediana dei peer
ROA
-52.3%
-51.4%
ROE
-151.1%
-78.8%
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
MPLT
Mediana dei peer
Current Ratio (Rapporto corrente)
20.0
9.0
Quick Ratio
18.8
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
MPLT
Mediana dei peer
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
MPLT
Mediana dei peer
MPLT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
13 analisti
- Acquisto forte 5 38,5%
- Compra 7 53,8%
- Mantieni 1 7,7%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
8 analisti · 2026-05-17
Mediana
$34.50
Media
$36.00
← Sotto tutti i target
$25.52
Basso
$28.00
Alto
$45.00
Target mediano
$34.50
+35,2%
Target medio
$36.00
+41,1%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-12.4%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Marzo 2026 | $-1.34 | $-1.12 | -0.22% |
| 31 Dicembre 2025 | $-2.47 | $-0.98 | -1.5% |
| 30 Settembre 2025 | $-37.18 | $-1.76 | -35.4% |
Confronto tra pari Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| MPLT | $773M | -0.9 | — | — | -151.1% | — |
| AVBP | $854M | -4.7 | — | — | -59.7% | — |
| OLMA | $2.03B | -13.4 | — | — | -39.4% | — |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
| JBIO | $761M | -4.8 | — | — | -47.7% | — |
| PURR | — | — | — | — | — | — |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | — |
| AKTS | — | — | — | — | — | — |
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 12
| Metrica | Tendenza | 2025 | 2024 |
|---|---|---|---|
| R&D Expense | $138M | $69M | |
| SG&A Expense | $31M | $14M | |
| Operating Expenses | $169M | $83M | |
| Operating Income | $-169M | $-83M | |
| Interest Income | $6M | $5M | |
| Other Non-op | $2M | $2M | |
| Net Income | $-161M | $-78M | |
| EPS (Basic) | $-18.56 | $-105.38 | |
| EPS (Diluted) | $-18.56 | $-105.38 | |
| Shares (Basic) | 8,680,741 | 736,178 | |
| Shares (Diluted) | 8,680,741 | 736,178 | |
| EBITDA | $-169M | · |
Stato Patrimoniale 20
| Metrica | Tendenza | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $47M | $38M | |
| Short-term Investments | $258M | $71M | |
| Prepaid Expense | $20M | $6M | |
| Current Assets | $325M | $115M | |
| PP&E (Net) | $1M | $1M | |
| PP&E (Gross) | $4M | $3M | |
| Accum. Depreciation | $3M | $2M | |
| Other Non-current Assets | $59.0K | $3M | |
| Total Assets | $480M | $137M | |
| Accounts Payable | $3M | $2M | |
| Accrued Liabilities | $12M | $10M | |
| Current Liabilities | $16M | $16M | |
| Capital Leases | $5M | $6M | |
| Total Liabilities | $21M | $22M | |
| Common Stock | $5.0K | $0 | |
| Retained Earnings | $-361M | $-199M | |
| AOCI | $-228.0K | $163.0K | |
| Stockholders' Equity | $458M | $-194M | |
| Liabilities + Equity | $480M | $137M | |
| Shares Outstanding | 44,024,088 | 761,276 |
Flusso di cassa 6
| Metrica | Tendenza | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $36M | $1M | |
| Operating Cash Flow | $-138M | $-79M | |
| CapEx | $473.0K | $770.0K | |
| Investing Cash Flow | $-323M | $-81M | |
| Financing Cash Flow | $470M | $118M | |
| Free Cash Flow | $-139M | · |
Redditività 2
| Metrica | Tendenza | 2025 | 2024 |
|---|---|---|---|
| ROA | -52.3% | · | |
| ROE | -151.1% | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 20.0 | · | |
| Quick Ratio | 18.8 | · |
Valutazione (TTM) 8
| Metrica | Tendenza | 2025 | 2024 |
|---|---|---|---|
| Net Income TTM | $-161M | · | |
| Market Cap | $773M | · | |
| P/E | -0.9 | · | |
| P/B | 1.7 | · | |
| P / Tangible Book | 1.7 | · | |
| P / Cash Flow | -5.6 | · | |
| P / FCF | -5.6 | · | |
| Earnings Yield | -105.7% | · |
Conto Economico 12
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| R&D Expense | $54M | $65M | $27M | $21M | |
| SG&A Expense | $11M | $19M | $4M | $2M | |
| Operating Expenses | $65M | $83M | $31M | $23M | |
| Operating Income | $-65M | $-83M | $-31M | $-23M | |
| Interest Income | $2M | $2M | $2M | $899.0K | |
| Other Non-op | $1M | $1M | $531.0K | $649.0K | |
| Net Income | $-61M | $-80M | $-29M | $-21M | |
| EPS (Basic) | $-1.34 | $87.14 | $-37.18 | $-28.01 | |
| EPS (Diluted) | $-1.34 | $87.14 | $-37.18 | $-28.01 | |
| Shares (Basic) | 45,276,763 | 7,908,710 | 791,127 | 7,835 | |
| Shares (Diluted) | 45,276,763 | 7,908,710 | 791,127 | 7,835 | |
| EBITDA | $-65M | · | $-31M | · |
Stato Patrimoniale 20
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Cash & Equivalents | $56M | $47M | $64M | $38M | |
| Short-term Investments | $254M | $258M | $163M | $71M | |
| Prepaid Expense | $17M | $20M | $18M | $6M | |
| Current Assets | $327M | $325M | $245M | $115M | |
| PP&E (Net) | $968.0K | $1M | $859.0K | $1M | |
| PP&E (Gross) | · | $4M | $3M | $3M | |
| Accum. Depreciation | · | $3M | $2M | $2M | |
| Other Non-current Assets | $36.0K | $59.0K | $5M | $3M | |
| Total Assets | $419M | $480M | $257M | $137M | |
| Accounts Payable | $3M | $3M | $2M | $2M | |
| Accrued Liabilities | $10M | $12M | $14M | $10M | |
| Current Liabilities | $14M | $16M | $19M | $16M | |
| Capital Leases | $5M | $5M | $5M | $6M | |
| Total Liabilities | $19M | $21M | $24M | $22M | |
| Common Stock | $5.0K | $5.0K | $0 | $0 | |
| Retained Earnings | $-421M | $-361M | $-281M | $-199M | |
| AOCI | $-883.0K | $-228.0K | $46.0K | $163.0K | |
| Stockholders' Equity | $400M | $458M | $-274M | $-194M | |
| Liabilities + Equity | $419M | $480M | $257M | $137M | |
| Shares Outstanding | 45,208,922 | 44,024,088 | 808,015 | 761,276 |
Flusso di cassa 6
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Stock-based Comp | $10M | $36M | · | $214.0K | |
| Operating Cash Flow | $-51M | $-47M | · | $-21M | |
| CapEx | $24.0K | $376.0K | · | $106.0K | |
| Investing Cash Flow | $67M | $-243M | · | $32M | |
| Financing Cash Flow | $-7M | $272M | · | $5.0K | |
| Free Cash Flow | $-51M | · | · | · |
Redditività 2
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| ROA | -29.0% | · | -22.9% | · | |
| ROE | -30.3% | · | 21.5% | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Current Ratio | 22.9 | · | 13.2 | · | |
| Quick Ratio | 21.7 | · | 12.2 | · |
Valutazione (TTM) 6
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Net Income TTM | $-142M | · | $-101M | · | |
| Market Cap | $919M | · | · | · | |
| P/B | 2.3 | · | · | · | |
| P / Tangible Book | 2.3 | · | · | · | |
| P / Cash Flow | -18.0 | · | · | · | |
| P / FCF | -18.0 | · | · | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Utile netto | $-161M | $-78M |
| EPS Diluito | $-18.56 | $-105.38 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Rapporto corrente | 20.0 | — |
| Quick Ratio | 18.8 | — |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Flusso di cassa libero | $-139M | — |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.